26th May 2021 16:29
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | UDG HEALTHCARE PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 25 May 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
5,386,770 | 2.14% | 368,378 | 0.15% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
310,415 | 0.12% | 4,926,555 | 1.96% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
5,697,185 | 2.26% | 5,294,933 | 2.10% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 842 | 10.6709 GBP |
Purchase | 1,497 | 10.6002 GBP |
Purchase | 3,149 | 10.6590 GBP |
Purchase | 4,379 | 10.5900 GBP |
Purchase | 6,025 | 10.6173 GBP |
Purchase | 12,957 | 10.6276 GBP |
Purchase | 14,877 | 10.6345 GBP |
Purchase | 15,865 | 10.6240 GBP |
Purchase | 17,439 | 10.6361 GBP |
Purchase | 28,724 | 10.6370 GBP |
Purchase | 38,578 | 10.6700 GBP |
Purchase | 83,673 | 10.6244 GBP |
Sale | 14 | 10.6300 GBP |
Sale | 264 | 10.6150 GBP |
Sale | 330 | 10.6000 GBP |
Sale | 378 | 10.6165 GBP |
Sale | 435 | 10.5957 GBP |
Sale | 480 | 10.6215 GBP |
Sale | 484 | 10.5905 GBP |
Sale | 697 | 10.6182 GBP |
Sale | 729 | 10.6305 GBP |
Sale | 732 | 10.6031 GBP |
Sale | 1,087 | 10.6210 GBP |
Sale | 1,169 | 10.6400 GBP |
Sale | 2,002 | 10.6217 GBP |
Sale | 2,366 | 10.6122 GBP |
Sale | 4,192 | 10.6253 GBP |
Sale | 4,611 | 10.6213 GBP |
Sale | 5,737 | 10.6419 GBP |
Sale | 6,617 | 10.5900 GBP |
Sale | 11,150 | 10.6301 GBP |
Sale | 25,377 | 10.6044 GBP |
Sale | 36,177 | 10.5913 GBP |
Sale | 80,160 | 10.6275 GBP |
Sale | 196,641 | 10.6360 GBP |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities | Price per |
| unit | |||
CFD | Long | 239 | 10.6123 GBP |
CFD | Long | 2,127 | 10.6122 GBP |
CFD | Long | 4,657 | 10.5885 GBP |
SWAP | Long | 6,425 | 10.5899 GBP |
SWAP | Long | 11,424 | 10.6537 GBP |
SWAP | Long | 16,315 | 10.6258 GBP |
SWAP | Long | 18,952 | 10.6094 GBP |
SWAP | Long | 29,511 | 10.6318 GBP |
SWAP | Long | 34,919 | 10.6229 GBP |
CFD | Short | 332 | 10.6709 GBP |
CFD | Short | 510 | 10.6710 GBP |
SWAP | Short | 1,910 | 10.5900 GBP |
SWAP | Short | 6,871 | 10.6776 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 26 May 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210526005850/en/
Copyright Business Wire 2021
Related Shares:
BarclaysUDG.L